KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Divestments (2017 - 2025)

Historic Divestments for Omega Healthcare Investors (OHI) over the last 9 years, with Q4 2025 value amounting to $2.9 million.

  • Omega Healthcare Investors' Divestments rose 26193.62% to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.9 million, marking a year-over-year increase of 116971.48%. This contributed to the annual value of $12.9 million for FY2025, which is 116971.48% up from last year.
  • Per Omega Healthcare Investors' latest filing, its Divestments stood at $2.9 million for Q4 2025, which was up 26193.62% from $8.5 million recorded in Q3 2025.
  • Over the past 5 years, Omega Healthcare Investors' Divestments peaked at $8.5 million during Q3 2025, and registered a low of -$1.8 million during Q4 2024.
  • In the last 5 years, Omega Healthcare Investors' Divestments had a median value of $1.1 million in 2022 and averaged $2.2 million.
  • Its Divestments has fluctuated over the past 5 years, first soared by 408379.89% in 2021, then plummeted by 13139.35% in 2024.
  • Omega Healthcare Investors' Divestments (Quarter) stood at $197000.0 in 2021, then surged by 911.68% to $2.0 million in 2022, then skyrocketed by 190.57% to $5.8 million in 2023, then tumbled by 131.39% to -$1.8 million in 2024, then surged by 261.94% to $2.9 million in 2025.
  • Its Divestments was $2.9 million in Q4 2025, compared to $8.5 million in Q3 2025 and $310000.0 in Q2 2025.